Spectral AI, Inc.

Spectral AI, Inc. develops predictive medical diagnostic solutions driven by artificial intelligence. Its primary offering is the DeepView System, which integrates multispectral imaging optics and sensors with proprietary algorithms to evaluate wound healing potential. The platform delivers immediate, binary assessments that differentiate between non-healing and healing tissue, particularly for burn indications. Its operational framework incorporates two commercial models: a software licensing structure featuring maintenance, data hosting, and algorithmic updates, alongside a proprietary imaging hardware component. These clinical tools are designed to assist healthcare professionals in making timely treatment and triage decisions across emergency rooms, trauma centers, and burn units.

The company maintains its principal executive offices in Dallas, Texas. Outside the United States, Spectral AI has obtained regulatory authorization to market its burn assessment technology in the United Kingdom, where commercial distribution is scheduled to commence. Additionally, through the Australian Special Access Scheme, the company has delivered diagnostic devices to three hospitals situated in Melbourne, Perth, and Sydney.

Summary of the business section of Spectral AI's latest annual report, written by StockData.

“At December 31, 2025 had 65 full-time employees in the United States”